Accuronix Therapeutics

Accuronix Therapeutics

 

Accuronix Therapeutics is a biotech company developing breakthrough treatments for the most difficult types of cancer. Accuronix was established based on technologies developed at Washington University in St. Louis by Dr. William Hawkins, Professor of Surgery, and his collaborator, Dr. Robert Mach, Professor of Radiology at University of Pennsylvania. With a particular focus in pancreatic cancer, the company’s mission is to develop novel oncology therapies founded on technology that selectively targets overexpressed receptors on cancer cells.